Earnings Per Share, Basic of OCULAR THERAPEUTIX, INC from 31 Mar 2018 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD/shares
- Description
- The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
- Summary
-
OCULAR THERAPEUTIX, INC quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Mar 2018 to 31 Dec 2025.
- OCULAR THERAPEUTIX, INC Earnings Per Share, Basic for the quarter ending 31 Dec 2025 was -0.27, a 8% decline year-over-year.
- OCULAR THERAPEUTIX, INC Earnings Per Share, Basic for the twelve months ending 31 Dec 2025 was -1.42, a 16% decline year-over-year.
- OCULAR THERAPEUTIX, INC annual Earnings Per Share, Basic for 2025 was -1.42, a 16% decline from 2024.
- OCULAR THERAPEUTIX, INC annual Earnings Per Share, Basic for 2024 was -1.22, a 21% decline from 2023.
- OCULAR THERAPEUTIX, INC annual Earnings Per Share, Basic for 2023 was -1.01, a 9.8% decline from 2022.
- Source SEC data
- View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)
OCULAR THERAPEUTIX, INC Quarterly Earnings Per Share, Basic (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.42 | -0.27 | -0.02 | -8% | 01 Oct 2025 | 31 Dec 2025 | 10-K | 05 Feb 2026 | 2025 | FY |
| Q3 2025 | -1.4 | -0.38 | -0.16 | -73% | 01 Jul 2025 | 30 Sep 2025 | 10-Q | 04 Nov 2025 | 2025 | Q3 |
| Q2 2025 | -1.24 | -0.39 | -0.13 | -50% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 05 Aug 2025 | 2025 | Q2 |
| Q1 2025 | -1.11 | -0.38 | +0.11 | +22% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 05 May 2025 | 2025 | Q1 |
| Q4 2024 | -1.22 | -0.25 | +0.1 | +29% | 01 Oct 2024 | 31 Dec 2024 | 10-K | 05 Feb 2026 | 2025 | FY |
| Q3 2024 | -1.32 | -0.22 | -0.21 | -2100% | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 04 Nov 2025 | 2025 | Q3 |
| Q2 2024 | -1.11 | -0.26 | 0 | 0% | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 05 Aug 2025 | 2025 | Q2 |
| Q1 2024 | -1.11 | -0.49 | -0.1 | -26% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 05 May 2025 | 2025 | Q1 |
| Q4 2023 | -1.01 | -0.35 | -0.14 | -67% | 01 Oct 2023 | 31 Dec 2023 | 10-K | 05 Feb 2026 | 2025 | FY |
| Q3 2023 | -0.87 | -0.01 | +0.3 | +97% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 14 Nov 2024 | 2024 | Q3 |
| Q2 2023 | -1.17 | -0.26 | -0.02 | -8.3% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 07 Aug 2024 | 2024 | Q2 |
| Q1 2023 | -1.15 | -0.39 | -0.23 | -144% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 07 May 2024 | 2024 | Q1 |
| Q4 2022 | -0.92 | -0.21 | -0.16 | -320% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 03 Mar 2025 | 2024 | FY |
| Q3 2022 | -0.76 | -0.31 | -0.34 | -1133% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 07 Nov 2023 | 2023 | Q3 |
| Q2 2022 | -0.42 | -0.24 | -0.13 | -118% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 07 Aug 2023 | 2023 | Q2 |
| Q1 2022 | -0.29 | -0.16 | -0.2 | -500% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 08 May 2023 | 2023 | Q1 |
| Q4 2021 | -0.09 | -0.05 | +1.27 | +96% | 01 Oct 2021 | 31 Dec 2021 | 10-K | 11 Mar 2024 | 2023 | FY |
| Q3 2021 | -1.36 | 0.03 | +0.22 | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 07 Nov 2022 | 2022 | Q3 | |
| Q2 2021 | -1.58 | -0.11 | +0.53 | +83% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 08 Aug 2022 | 2022 | Q2 |
| Q1 2021 | -2.11 | 0.04 | +0.45 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 09 May 2022 | 2022 | Q1 | |
| Q4 2020 | -2.56 | -1.32 | -0.79 | -149% | 01 Oct 2020 | 31 Dec 2020 | 10-K | 06 Mar 2023 | 2022 | FY |
| Q3 2020 | -1.77 | -0.19 | +0.21 | +52% | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 08 Nov 2021 | 2021 | Q3 |
| Q2 2020 | -1.98 | -0.64 | -0.07 | -12% | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 09 Aug 2021 | 2021 | Q2 |
| Q1 2020 | -1.91 | -0.41 | 0 | 0% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 05 May 2021 | 2021 | Q1 |
| Q4 2019 | -1.91 | -0.53 | -0.11 | -26% | 01 Oct 2019 | 31 Dec 2019 | 10-K | 12 Mar 2020 | 2019 | FY |
| Q3 2019 | -1.8 | -0.4 | -0.02 | -5.3% | 01 Jul 2019 | 30 Sep 2019 | 10-Q | 05 Nov 2020 | 2020 | Q3 |
| Q2 2019 | -1.78 | -0.57 | -0.2 | -54% | 01 Apr 2019 | 30 Jun 2019 | 10-K | 12 Mar 2020 | 2019 | FY |
| Q1 2019 | -1.58 | -0.41 | -0.01 | -2.5% | 01 Jan 2019 | 31 Mar 2019 | 10-Q | 08 May 2020 | 2020 | Q1 |
| Q4 2018 | -1.57 | -0.42 | 01 Oct 2018 | 31 Dec 2018 | 10-K | 12 Mar 2020 | 2019 | FY | ||
| Q3 2018 | -0.38 | 01 Jul 2018 | 30 Sep 2018 | 10-K | 12 Mar 2020 | 2019 | FY | |||
| Q2 2018 | -0.37 | 01 Apr 2018 | 30 Jun 2018 | 10-K | 12 Mar 2020 | 2019 | FY | |||
| Q1 2018 | -0.4 | 01 Jan 2018 | 31 Mar 2018 | 10-K | 12 Mar 2020 | 2019 | FY |
OCULAR THERAPEUTIX, INC Annual Earnings Per Share, Basic (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | -1.42 | -0.2 | -16% | 01 Jan 2025 | 31 Dec 2025 | 10-K | 05 Feb 2026 | 2025 | FY |
| 2024 | -1.22 | -0.21 | -21% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 05 Feb 2026 | 2025 | FY |
| 2023 | -1.01 | -0.09 | -9.8% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 05 Feb 2026 | 2025 | FY |
| 2022 | -0.92 | -0.83 | -922% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 03 Mar 2025 | 2024 | FY |
| 2021 | -0.09 | +2.47 | +96% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 11 Mar 2024 | 2023 | FY |
| 2020 | -2.56 | -0.65 | -34% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 06 Mar 2023 | 2022 | FY |
| 2019 | -1.91 | 01 Jan 2019 | 31 Dec 2019 | 10-K | 28 Feb 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.